Pear Therapeutics (US)

About Prescription Digital Therapeutics

Prescription Digital Therapeutics, or PDTs, are a new therapeutic class.

Similar to traditional biologics or drugs, PDTs:

  • Directly treat serious diseases
  • Are built under current Good Manufacturing Practices
  • Demonstrate safety and efficacy in randomized clinical trials
  • Receive labeled claims from the FDA
  • Are used by physician prescription
  • Are reimbursed as products, via Pharmacy and Medical benefits
  • Have barriers to entry that span regulatory exclusivity and intellectual property

Pear Therapeutics is the leader in this new sector and has built a pipeline of potential new therapies across disease areas.